Recombinant Human Epiregulin Protein, Active
Beta LifeScience
SKU/CAT #: BEP-0054
Recombinant Human Epiregulin Protein, Active
Beta LifeScience
SKU/CAT #: BEP-0054
Regular price$84400
$844.00
/
Submit an inquiry or email sales for a custom bulk quote. Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Connect with us via the live chat in the bottom corner to receive immediate assistance.
Product Overview
| Product Name | Recombinant Human Epiregulin Protein |
| Target Symbol | EREG |
| Alternative Names | EREG, Proepiregulin |
| Accession Number | O14944 |
| Expression System | E. coli. |
| Molecular Weight | 5.7 kDa (predicted) |
| Sequence | Val60-Leu108, with an N-terminal Met |
| Purity | Determined by SDS-PAGE and quantitative densitometry by Coomassie® Blue staining |
| Activity | Determined by in-house activity assay |
| Formulation | Lyophilized from sterile PBS with Trehalose, pH 7.4 |
| Endotoxin Level | Available Upon Request |
| Shipping | Shipped at ambient temperature. |
| Stability & Storage | 12 months from date of receipt at -20°C to -70°C, lyophilized powder. 3 months at -20°C to -70°C under sterile conditions after reconstitution. Avoid repeated freeze-thaw cycles. |
| Reconstitution | Reconstitute at 100 ug/mL in sterile PBS. |
| Target Function | Epiregulin is a widely expressed growth factor involved in cell growth, proliferation, differentiation, and tissue repair. Epiregulin is expressed by peripheral blood macrophages and normal keratinocytes in response to tissue damage which promotes inflammation, angiogenesis and fibroblast-mediated wound healing. Epiregulin is also produced in the placenta, uterus and during ovarian follicle formation. Epiregulin promotes the proliferation of smooth muscle cells and hepatocytes. Signaling by Epiregulin occurs with the binding of EGFR (ErbB1) or ErbB4. |
| Tissue Specificity | Epiregulin expression has been identified in skin, gastrointestinal tract, respiratory tract, ovaries, uterus, placenta, liver, brain, kidney, pancreas, and adipose tissues. |
| Cellular Localization | Membrane-bound and cleaved soluble protein forms |
| Involvement In Disease | Dysregulation of Epiregulin is associated with atherosclerosis, cardiac hypertrophy, polycystic ovary syndrome (PCOS), psoriasis, atopic dermatitis, inflammatory bowel disease (IBD), rheumatoid arthritis, and various cancers (breast cancer, colorectal cancer, lung cancer, ovarian cancer) due to tumor growth and metastasis. |
